Sean P. Nolan - Aug 16, 2023 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Chief Executive Officer, Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Stock symbol
TSHA
Transactions as of
Aug 16, 2023
Transactions value $
$400,000
Form type
4
Date filed
8/16/2023, 08:52 PM
Previous filing
May 18, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $400K +444K +40.73% $0.90 1.54M Aug 16, 2023 See Footnote F1
holding TSHA Common Stock 1.17K Aug 16, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.